These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8132847)

  • 1. Treatment of human immunodeficiency virus infection and its associated complications in children.
    Brady MT
    J Clin Pharmacol; 1994 Jan; 34(1):17-29. PubMed ID: 8132847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
    Iribarren JA; Rubio R; Aguirrebengoa K; Arribas JR; Baraia-Etxaburu J; Gutiérrez F; Lopez Bernaldo de Quirós JC; Losa JE; Miró JM; Moreno S; Pérez Molina J; Podzamczer D; Pulido F; Riera M; Rivero A; Sanz Moreno J; Amador C; Antela A; Arazo P; Arrizabalaga J; Bachiller P; Barros C; Berenguer J; Caylá J; Domingo P; Estrada V; Knobel H; Locutura J; López Aldeguer J; Llibre JM; Lozano F; Mallolas J; Malmierca E; Miralles C; Miralles P; Muñoz A; Ocampo A; Olalla J; Pérez I; Pérez Elías MJ; Pérez Arellano JL; Portilla J; Ribera E; Rodríguez F; Santín M; Sanz Sanz J; Téllez MJ; Torralba M; Valencia E; Von Wichmann MA;
    Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):516.e1-516.e18. PubMed ID: 26976381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
    Iribarren JA; Rubio R; Aguirrebengoa K; Arribas JR; Baraia-Etxaburu J; Gutiérrez F; Lopez Bernaldo de Quirós JC; Losa JE; Miró JM; Moreno S; Pérez Molina J; Podzamczer D; Pulido F; Riera M; Rivero A; Sanz Moreno J; Amador C; Antela A; Arazo P; Arrizabalaga J; Bachiller P; Barros C; Berenguer J; Caylá J; Domingo P; Estrada V; Knobel H; Locutura J; López Aldeguer J; Llibre JM; Lozano F; Mallolas J; Malmierca E; Miralles C; Miralles P; Muñoz A; Ocampo A; Olalla J; Pérez I; Pérez Elías MJ; Pérez Arellano JL; Portilla J; Ribera E; Rodríguez F; Santín M; Sanz Sanz J; Téllez MJ; Torralba M; Valencia E; Von Wichmann MA;
    Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):517-23. PubMed ID: 27056581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of opportunistic infections].
    Nevot Falcó S; Bartralot Soler J
    Allergol Immunopathol (Madr); 1998; 26(3):144-50. PubMed ID: 9675398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care of children with HIV infection.
    Forsyth BW
    Curr Opin Pediatr; 1995 Oct; 7(5):502-12. PubMed ID: 8541949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee].
    ;
    Enferm Infecc Microbiol Clin; 2008; 26(6):356-79. PubMed ID: 18588819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
    Mofenson LM; Moye J
    Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; McNeil MM; Schonberger LB; Navin TR; Hanson DL; Gross PA; Jaffe HW
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S1-11. PubMed ID: 8547495
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
    Dankner WM; Lindsey JC; Levin MJ;
    Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications following renal transplantation.
    Sia IG; Paya CV
    Surg Clin North Am; 1998 Feb; 78(1):95-112. PubMed ID: 9531938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.